Summary
Epidemiological studies show that non-steroidal anti-inflammatory drugs (NSAIDs) reduce colorectal cancer incidence. We measured the rate ratio for colorectal adenocarcinoma according to dosage and the timing of exposure by means of a case–control study, nested in a non-concurrent cohort linkage study, using the population of beneficiaries of the Saskatchewan Prescription Drug Plan from 1981 to 1995 with no history of cancer since 1970 as the source population. Four controls per case, matched on age and gender and alive when the case was diagnosed, were randomly selected. Dispensing rates, calculated over successive time periods, characterized NSAID exposure. We accrued 3844 cases of colon cancer and 1971 cases of rectal cancer. For colon cancer a significant trend towards a decreasing rate ratio was associated with increasing exposure during the 6 months preceding diagnosis (P-trend = 0.002). For both cancers, significant trends were associated with exposure 11–15 years before diagnosis (colon: P-trend = 0.01; rectum: P-trend = 0.0001). At the highest exposure levels the rate ratio for colon cancer was 0.57 (95% confidence interval (CI) 0.36–0.89); for rectal cancer it was 0.26 (95% CI 0.11–0.61). No protection was associated with exposure during other periods. The timing of NSAID use must be considered in planning intervention trials to prevent colorectal cancer. There may be a 10-year delay before any preventive effect will appear.
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Berkel, HJ, Holcombe, RF, Middlebrooks, M & Kannan, K (1996). Nonsteroidal antiinflammatory drugs and colorectal cancer. Epidemiol Rev 18: 205–217.
Birkenfeld, S, Zaltsman, YA, Krispin, M, Zakut, H, Zor, U & Kohen, F (1987). Antitumor effects of inhibitors of arachidonic acid cascade on experimentally induced intestinal tumors. Dis Colon Rectum 30: 43–46.
Brenner, H & Gefeller, O (1993). Use of the positive predictive value to correct for disease misclassification in epidemiologic studies. Am J Epidemiol 138: 1007–1015.
Breslow, NE & Day, NE (1980). Statistical Methods in Cancer Research. Volume I – The Analysis of Case–control Studies. International Agency for Research on Cancer: Lyon
Carson, JL, Strom, B, Morse, ML, West, SL, Soper, KA & Stolley, PD, et al (1987). The relative gastrointestinal toxicity of the nonsteroidal anti-inflammatory drugs. Arch Int Med 147: 1054–1059.
Krogh, CME (ed) (1995). Compendium of Pharmaceuticals and Specialties, 30th edition. Canadian Pharmaceutical Association: Ottawa
Gann, PH, Manson, JE, Glynn, RJ, Burling, JE & Hennekens, CH (1993). Low-dose aspirin and incidence of colorectal tumors in a randomized clinical trial. J Natl Cancer Inst 85: 1220–1224.
Giovannucci, E, Colditz, GA, Stampfer, MJ, Hunter, D, Rosner, BA & Willett, WC et al (1994a). A prospective study of cigarette smoking and risk of colorectal adenoma and colorectal cancer in U.S. women. J Natl Cancer Inst 86: 192–199.
Giovannucci, E, Rimm, EB, Stampfer, MJ, Colditz, GA, Ascherio, A & Kearney, J et al (1994b). A prospective study of cigarette smoking and risk of colorectal adenoma and colorectal cancer in U.S. men. J Natl Cancer Inst 86: 183–191.
Giovannucci, E, Rimm, EB, Stampfer, MJ, Colditz, GA, Ascherio, A & Willett, WC (1994c). Aspirin use and the risk of colorectal cancer and adenoma in male health professionals. Ann Intern Med 121: 241–246.
Giovannucci, E, Egan, KM, Hunter, DJ, Stampfer, MJ, Colditz, GA & Willett, WC (1995). Aspirin and the risk of colorectal cancer in women. N Eng J Med 333: 609–614.
Gridley, G, McLaughlin, JK, Ekbom, A, Klareskog, L, Adami, HO & Hacker, DG (1993). Incidence of cancer among patients with rheumatoid arthritis. J Natl Cancer Inst 85: 307–311.
Lundholm, K, Gelin, J, Hyltander, A, Lönnroth, C, Sandström, R & Svaninger, G (1994). Anti-inflammatory treatment may prolong survival in undernourished patients with metastatic solid tumors. Cancer Res 54: 5602–5606.
MacMahon, B & Trichopoulos, D (1996). Epidemiology. Principles and Methods. Second Edition. Little, Brown: Boston
Marshall, JR, Priore, R, Graham, S & Brasure, J (1981). On the distortion of risk estimates in multiple exposure level case–control studies. Am J Epidemiol 113: 464–473.
Miettinen, OS (1985). Theoretical Epidemiology. Principles of occurrence research in medicine. Delmar: Albany
Newcomb, PA & Storer, BE (1995). Postmenopausal hormone use and risk of large-bowel cancer. J Natl Cancer Inst 87: 1067–1071.
Paganini-Hill, A, Chao, A, Ross, RK & Henderson, BE (1989). Aspirin use and chronic diseases: a cohort study of the elderly. Br Med J 299: 1247–1250.
Parkin, DM, Whelan, SL, Ferlay, J, Raymond, L & Young, J (eds.) (1997). Cancer Incidence in Five Continents. Volume VII. International Agency for Research on Cancer: Lyon
Peleg, II, Lubin, MF, Cotsonis, GA, Clark, WS & Wilcox, CM (1996). Long-term use of nonsteroidal antiinflammatory drugs and other chemopreventors and risk of subsequent colorectal neoplasia. Dig Dis Sci 41: 1319–1326.
Pollard, M & Luckert, PH (1981). Effect of indomethacin on intestinal tumors induced in rats by the acetate derivate of dimethylnitrosamine. Science 214: 558–559.
Potter, JD, Slattery, ML, Bostick, RM & Gapstur, SM (1993). Colon cancer: a review of the epidemiology. Epidemiol Rev 15: 499–545.
Rawson, NSB, D’Arcy, C, Blackburn, JL, Bowen, RC, Wallace, SM & Downey, W et al (1992). Epidemiologic research using linked computerized health care datafiles in Saskatchewan, Canada. Technical Report Series. In Report #2. Psychiatric Pharmacoepidemiology Research Consortium: Saskatoon
Risch, HA & Howe, GR (1994). Menopausal hormone usage and breast cancer in Saskatchewan: a record-linkage study. Am J Epidemiol 139: 670–683.
Rosenberg, L, Palmer, JR, Zauber, AG, Warshauer, E, Stolley, PD & Shapiro, S (1991). A hypothesis: nonsteroidal anti-inflammatory drugs reduce the incidence of large-bowel cancer. J Natl Cancer Inst 83: 355–358.
Rothman, KJ & Greenland, S (1998). Modern Epidemiology, 2nd edition. Lippincott–Raven: Philadelphia
Rothman, KJ (1981). Induction and latent periods. Am J Epidemiol 114: 253–259.
SAS Institute (1992). SAS/STAT software: changes and enhancements, release 6.07. In: SAS Technical Report P-229. SAS Institute: Cary, NC
Schreinemachers, DM & Everson, RB (1994). Aspirin use and lung, colon and breast cancer incidence in a prospective study. Epidemiology 5: 138–146.
Thun, MJ, Namboodiri, MM & Health, CW (1991). Aspirin use and reduced risk of fatal colon cancer. N Eng J Med 325: 1593–1596.
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Collet, JP., Sharpe, C., Belzile, E. et al. Colorectal cancer prevention by non-steroidal anti-inflammatory drugs: effects of dosage and timing. Br J Cancer 81, 62–68 (1999). https://doi.org/10.1038/sj.bjc.6690651
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bjc.6690651
Keywords
This article is cited by
-
Non-Steroidal Anti-Inflammatory Drugs and Colorectal Cancer Risk in a Large, Prospective Cohort
American Journal of Gastroenterology (2011)
-
Prevention by Aspirin of Colorectal Adenoma Recurrence: Some Advances and Latest Results of the APACC Trial
Current Colorectal Cancer Reports (2011)
-
Non-Steroidal Anti-Inflammatory Drug Use and Colorectal Polyps in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial
American Journal of Gastroenterology (2010)
-
Aspirin and other non-steroidal anti-inflammatory drugs and risk of colorectal cancer: A Danish cohort study
Cancer Causes & Control (2009)
-
Aspirin and lung cancer risk in a cohort study of women: dosage, duration and latency
British Journal of Cancer (2007)